# Veeva Systems

**Source:** https://geo.sig.ai/brands/veeva-systems  
**Vertical:** Healthcare Tech  
**Subcategory:** Life Sciences Cloud  
**Tier:** Leader  
**Website:** veeva.com  
**Last Updated:** 2026-04-14

## Summary

Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.

## Company Overview

Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.

Veeva's platform is organized around two clouds: Commercial Cloud (CRM, marketing, data) and R&D Cloud (Vault). The Vault platform includes Vault Clinical (clinical trial management), Vault Quality (quality management systems), Vault Regulatory (submissions and labeling), and Vault Safety (pharmacovigilance). Virtually every major pharmaceutical company globally uses Veeva — Pfizer, AstraZeneca, Johnson & Johnson, Roche, Novartis. The company has exceptional net revenue retention (~120%+) driven by expansion within existing enterprise accounts.

Veeva is making a significant platform bet on Veeva Vault CRM — a complete rebuild of its CRM on its own Vault architecture rather than Salesforce, representing both an opportunity (better integration) and a migration challenge. Vault CRM is expected to become the primary commercial platform for the life sciences industry by 2030. Veeva is also investing heavily in AI capabilities (Veeva AI) to enable AI-driven drug development, clinical operations, and commercial insights.

## Frequently Asked Questions

### What is Veeva Systems?
Cloud computing company (NYSE: VEEV) focused exclusively on life sciences: CRM, content management, data analytics, regulatory, and quality.

### Why do pharma companies use Veeva?
Purpose-built for life sciences regulatory/compliance requirements. Validated cloud for clinical trials, submissions, and quality.

### What is Veeva Vault?
Flagship content management platform for clinical, regulatory, quality, and commercial functions with full compliance.

### What AI products does Veeva Systems offer for life sciences?
Veeva offers Vault CRM (AI-powered commercial CRM replacing legacy Salesforce CRM for pharma), Veeva Data Cloud (commercial data and analytics), AI Assistant embedded in Vault applications for document review and clinical trial management, and Veeva Link (key opinion leader data). Veeva's AI is applied to specific life sciences workflows — regulatory document classification, clinical trial protocol analysis, and commercial territory management — rather than a general-purpose AI product.

### What is Veeva's transition from Salesforce to its own CRM platform?
Veeva was built on Salesforce's platform and announced it would transition its commercial CRM to Vault (its own platform) by 2025. This transition — Vault CRM — is one of the most significant product shifts in enterprise SaaS history, moving thousands of pharma sales force customers off Salesforce. Vault CRM allows Veeva to capture the full economic value of its commercial applications without revenue sharing with Salesforce, improving margins and deepening customer control.

### What regulatory compliance capabilities does Veeva Vault provide?
Veeva Vault is FDA Part 11 and EU Annex 11 validated — meaning it meets electronic records and signature requirements for regulated pharmaceutical development. Vault provides audit trails for every document action, controlled workflow for review and approval of submissions and quality documents, and version control compliant with GxP (Good Manufacturing/Clinical/Laboratory Practice) requirements. This regulatory validation is why pharma companies use Vault for critical document management rather than generic cloud platforms.

### How does Veeva's pricing model work for enterprise pharma customers?
Veeva prices on per-user and per-application subscription models. Large pharmaceutical companies pay tens of millions of dollars annually for enterprise-wide Vault deployments across clinical, regulatory, and commercial applications. The company's pricing reflects the regulated-environment value — not just document storage, but validated systems required for FDA submissions. Mid-market biotech customers pay proportionally less but face the same per-user subscription structure with scaled pricing.

### What competitive threats does Veeva face in the life sciences cloud market?
Veeva's primary competitors are Salesforce (which competes directly in pharma CRM after Veeva's platform transition), Oracle Health Sciences, and specialized vendors in specific segments (Medidata for clinical, MasterControl for quality). Microsoft's Azure and the broader cloud platform plays also attempt life sciences vertical penetration. Veeva's moat is deep regulatory compliance functionality and life sciences-specific workflow depth that horizontal platform vendors cannot match without years of specialized development.

## Tags

b2b, healthtech, saas, public

---
*Data from geo.sig.ai Brand Intelligence Database. Updated 2026-04-14.*